Search hospitals > Maryland > Rosedale
Franklin Square Hospital Center
Claim this profileRosedale, Maryland 21237
Global Leader in Breast Cancer
Global Leader in Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Skin Cancer
Conducts research for Heart Failure
92 reported clinical trials
4 medical researchers
Summary
Franklin Square Hospital Center is a medical facility located in Rosedale, Maryland. This center is recognized for care of Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Skin Cancer, Heart Failure and other specialties. Franklin Square Hospital Center is involved with conducting 92 clinical trials across 143 conditions. There are 4 research doctors associated with this hospital, such as Edward McCarron, Dr. Gary Volkel, MD, Shawna Willey, MD, and Derrick Fox.Area of expertise
1Breast Cancer
Global Leader2Non-Small Cell Lung Cancer
Global LeaderStage IV
EGFR negative
ALK negative
Top PIs
Edward McCarronMedStar Franklin Square Medical Center/Weinberg Cancer Institute9 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
9 drugs studied
Dr. Gary Volkel, MDMedStar Health Research Institute2 years of reported clinical research
Studies Caregiver Burden
Studies Aggression
1 reported clinical trial
1 drug studied
Shawna Willey, MDMedStar Washington Hospital Center9 years of reported clinical research
Studies Esophageal Papilloma
Studies Intraductal Papilloma
1 reported clinical trial
1 drug studied
Derrick FoxMedStar Franklin Square Medical Center1 year of reported clinical research
Studies Systemic Lupus Erythematosus
Studies Myositis
1 reported clinical trial
2 drugs studied
Clinical Trials running at Franklin Square Hospital Center
Lung Cancer
Non-Small Cell Lung Cancer
Stroke
Colorectal Cancer
Breast Cancer
Skin Cancer
Lymphoma
Cardiovascular Disease
Mitral Regurgitation
Valvular Heart Disease
Pembrolizumab + Investigational Agents
for Lung Cancer
The main goals are after treatment given before surgery, to measure the number of people who have no signs of cancer cells in tumors and lymph nodes removed during surgery; and to learn about whether the cancer gets smaller or goes away by measuring the number of people with a certain number of living cancer cells in the tumor removed during surgery.
Recruiting1 award Phase 2
Pembrolizumab + Chemotherapy
for Lung Cancer
Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common form of lung cancer and lung cancer that has spread beyond surgical removal. Standard treatments include immunotherapy, such as pembrolizumab, and chemotherapy. This study aims to determine the effectiveness of adding other treatments, including the human epidermal growth factor receptor 3-directed antibody-drug conjugate (HER3-DXd) patritumab deruxtecan, to pembrolizumab, with or without chemotherapy. The primary goals are to assess safety and efficacy of the treatments.
Recruiting1 award Phase 23 criteria
Investigational Agents
for Lung Cancer
Researchers are looking for other ways to treat metastatic squamous non-small cell lung cancer (NSCLC). Squamous NSCLC is cancer that starts in squamous cells, which are flat cells that line the inside of the airways in the lungs. Metastatic means the cancer has spread to other parts of the body. Standard treatment (usual treatment) for metastatic squamous NSCLC is immunotherapy with or without chemotherapy. Immunotherapy is a treatment that helps the immune system fight cancer. Chemotherapy is medicine that destroys cancer cells or stops them from growing. However, standard treatment may not work or may stop working to treat metastatic squamous NSCLC. Researchers want to learn if study treatments that are antibody drug conjugates (ADCs) can treat metastatic squamous NSCLC that did not respond (get smaller or go away) to standard treatment. An ADC attaches to a protein on cancer cells and delivers treatment to destroy those cells. The main goals of this study are to learn about: * The cancer response to the study treatments compared to chemotherapy * The safety of the study treatments and if people tolerate them This study is one of the substudies being conducted under one pembrolizumab umbrella master protocol (MK-3475-U01/KEYMAKER-U01).
Recruiting1 award Phase 23 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Franklin Square Hospital Center?
Franklin Square Hospital Center is a medical facility located in Rosedale, Maryland. This center is recognized for care of Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Skin Cancer, Heart Failure and other specialties. Franklin Square Hospital Center is involved with conducting 92 clinical trials across 143 conditions. There are 4 research doctors associated with this hospital, such as Edward McCarron, Dr. Gary Volkel, MD, Shawna Willey, MD, and Derrick Fox.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.